Latest News

ToxStrategies is pleased to announce that we are partnering with Feeding America to help provide food to the millions of Americans currently in need. Feeding… read more

ToxStrategies scientists have developed a range of plausible toxicity values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on application of systematic review methods and quantitative integration… read more

  ToxStrategies is excited to be participating in the Society for Risk Analysis (SRA)’s 2020 Annual Meeting, which will be held virtually December 13-17th. We have two virtual poster presentations this year.    Camarie… read more

EpidStrategies is excited to be participating in the American Society of Hematology (ASH) Annual Meeting, which will be held virtually on December 5-8, 2020.  Xiaohui Jiang will… read more

ToxStrategies scientists Dr. Mark Harris, Dr. Deborah Proctor, and Dr. Chad Thompson are among the authors of a recently published study that proposes a cytotoxicity-mediated adverse outcome… read more

ToxStrategies is pleased to announce that Dr. Kristina Ulrich has joined our Biopharmaceuticals and Pharmaceuticals practice. Dr. Ulrich is a European Registered Toxicologist (ERT) and a… read more

Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian… read more

ToxStrategies scientist, Dr. Laurie Haws was recently elected to the Board of Directors for The Toxicology Forum. The Toxicology Forum is a leading… read more